Pure Biologics S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was PLN 7.6 million compared to PLN 6.42 million a year ago. Basic loss per share from continuing operations was PLN 2.36 compared to PLN 2.85 a year ago.
For the nine months, net loss was PLN 24.56 million compared to PLN 18.44 million a year ago. Basic loss per share from continuing operations was PLN 7.75 compared to PLN 8.18 a year ago.